#DYK Primary myelofibrosis, a subtype of MPN, is a rare condition that affects approximately 1 in 500,000 people worldwide? We are committed to helping meet the needs of patients, including those with rare blood cancers, through raising awareness, education and research. This #MPNAwarenessDay, learn more about the ongoing clinical trials being done to further advance the treatment of this rare group of diseases here: https://one.bms.com/45WaXIH | Bristol Myers Squibb

Some of the terms used to describe myelofibrosis (MF) symptoms can be confusing and overwhelming. In this video, Professor Harrison breaks down the meaning behind some of the more complex symptoms associated with blood cell counts to help empower people living with MF to self-advocate when seeking care. Watch the full #MappingMF episode here: https://gsk.to/3NOuLK5 | GSK